CHEMOTHERAPY FOR BREAST CANCER STAGE 1
Tìm thấy 10,000 tài liệu liên quan tới từ khóa "CHEMOTHERAPY FOR BREAST CANCER STAGE 1":
BÁO CÁO HÓA HỌC ENCAPSULATION OF DOCETAXEL IN OILY CORE POLYESTER NANOCAPSULE INTENDED FOR BREAST CANCER THERAPY DOCX
Powder X-ray diffraction pattern analysis Powder X-ray diffraction [PXRD] analysis of the freeze-dried NCs was performed using a MiniFlex automated X-ray diffractometer (Rigaku, The Woodlands, TX, USA) at room temperature. Ni-filtered Cu Kα radiation was used at 30 kV and 15 mA. The diffraction angl[r]
24 Đọc thêm
BÁO CÁO HÓA HỌC ENCAPSULATION OF DOCETAXEL IN OILY CORE POLYESTER NANOCAPSULE INTENDED FOR BREAST CANCER THERAPY PPT
emulsion solvent diffusion method using neutral Labrafac CC and poly(d,l-lactide) [PLA] as oily core and shell, respectively. The engineered NCs were characterized for particle size, zeta potential, EE%, drug release kinetics, morphology, crystallinity, and cytotoxicity on the SUM 225 brea[r]
24 Đọc thêm
BÁO CÁO SINH HỌC ENCAPSULATION OF DOCETAXEL IN OILY CORE POLYESTER NANOCAPSULE INTENDED FOR BREAST CANCER THERAPY PPTX
target site in its therapeutic concentration and preventing drug inefficiency and side effect. The current research was aimed to prepare highly loaded docetaxel [Doc] oily core nanocapsules [NCs]. Doc, a semisynthetic analog of paclitaxel, is an extract from the needles of the European yew tree Tax[r]
24 Đọc thêm
BÁO CÁO Y HỌC ANTICANCER ACTIVITY OF THE PR DOMAIN OF TUMOR SUPPRESSOR RIZ1
and proto-oncoprotein RIZ2, which regulate cellular functions in a Yin-Yang fashion. The only structural difference between them is that RIZ2 lacks the N-terminal PR domain. In this study, we showed that RIZ1 mRNA expression level was elevated in stage IV of eight different types of
Xem Thêm " CIRCULATING METHYLATED DNA AS BIOMARKERS FOR CANCER DETECTION "
7 Đọc thêm
NOVEL APPLICATIONS OF THE UWB TECHNOLOGIES PART 13 PPT
reflection exists. However, the location of the tumor in the signal is not known prior to thedetection process.This work introduces a new approach in removing the skin reflection from the backscatteredsignal in UWB breast cancer detection. In this approach, the backscattered signals area[r]
30 Đọc thêm
TÀI LIỆU WOMEN’S HEALTH HIGHLIGHTS RECENT FINDINGS PPTX
to an oncologist. To address thisproblem, researchers developed atracking system to facilitate followupwith breast cancer patients. Theycompared the treatment of 639 womenwith early stage breast cancer who wereseen at six New York City hospitalsbetween January 1999[r]
24 Đọc thêm
Design of a randomized controlled trial of a partnership-based, needs-tailored selfmanagement support intervention for posttreatment breast cancer survivors
Self-management is becoming essential for breast cancer survivors, but evidence about the effectiveness of self-management support (SMS) intervention is lacking. To address this issue, we developed a theory-based SMS intervention, the ‘EMPOWER’, aimed at empowering breast cancer survivors. Here we d[r]
CANCER AND THE ENVIRONMENT: WHAT YOU NEED TO KNOW WHAT YOU CAN DO DOC
people move from one country to another. For example, when Asians, who have low rates of prostate and breast cancer and high rates of stomach cancer in their native countries, immigrate to the United States, their prostate and breast cancer rates rise over t[r]
46 Đọc thêm
BÁO CÁO HÓA HỌC:" PAR1 IS SELECTIVELY OVER EXPRESSED IN HIGH GRADE BREAST CANCER PATIENTS: A COHORT STUDY" DOCX
noma breast cancer cell line, MCF-7, which is minimallyinvasive, expresses only trace amounts of PAR1 and lowlevels of PAR2 and PAR4. These data are consistent withfindings showing that high levels of PAR1 mRNA arefound in infiltrating ductal carcinoma, whereas very lowam[r]
10 Đọc thêm
REDUCING THE RISK OF BREAST CANCER WITH MEDICINE: A GUIDE FOR WOMEN POTX
This guide does not talk about screening for breast cancer. It alsodoes not cover treatments for women who already have breast cancer. Most women will never get breast cancer. A woman’s risk of breastcancer depends on her age and other risk fac[r]
16 Đọc thêm
CHAPTER 086. BREAST CANCER (PART 10) PPTX
endocrine therapies; however, combination endocrine therapies do not appear to be superior to individual agents, and combinations of chemotherapy with endocrine therapy are not useful. The median survival of patients with metastatic disease is approximately 2 years, and many patients, particu[r]
5 Đọc thêm
BÁO CÁO HÓA HỌC: " MASS SPECTROMETRY-BASED ANALYSIS OF THERAPY-RELATED CHANGES IN SERUM PROTEOME PATTERNS OF PATIENTS WITH EARLY-STAGE BREAST CANCER" POT
systematic review. J Proteome Res 2008, 7:1395-1402.31. Pusztai L, Gregory BW, Baggerly KA, Peng B, Koomen J, Kuerer HM, Esteva FJ, Symmans WF, Wagner P, Hortobagyi GN, Laronga C, Semmes OJ, Wright GL, Drake RR, Vlahou A: Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samp[r]
11 Đọc thêm
NEW MALIGNANCIES FOLLOWING BREAST CANCER DOCX
dard dose cyclophosphamide-methotrexate-fluorouracil(CMF) chemotherapy (Curtis et al, 1992; Valagussa et al,1994; Tallman et al, 1995; Kaplan et al, 2004).Cyclophophamide-anthracycline-based regimens, inwider use in recent years, may be associated with high-er leukemia risks, but in absolute[r]
26 Đọc thêm
DELAYED PRESENTATION IN BREAST CANCER: A STUDY IN IRANIAN WOMEN DOCX
BioMed CentralPage 1 of 6(page number not for citation purposes)BMC Women's HealthOpen AccessResearch articleDelayed presentation in breast cancer: a study in Iranian womenAli Montazeri*, Mandana Ebrahimi, Neda Mehrdad, Mariam Ansari and Akram SajadianAddress: Iranian Cen[r]
6 Đọc thêm
BÁO CÁO HÓA HỌC:" MASS SPECTROMETRY-BASED SERUM PROTEOME PATTERN ANALYSIS IN MOLECULAR DIAGNOSTICS OF EARLY STAGE BREAST CANCER" PDF
women). Serum specimens were purified and the low-molecular-weight proteome fraction wasexamined using MALDI-ToF mass spectrometry after removal of albumin and other high-molecular-weight serum proteins. Protein ions registered in a mass range between 2,000 and10,000 Da were analyzed using a new bio[r]
13 Đọc thêm
Cardiovascular disease events within 5 years after a diagnosis of breast cancer
Concern for cardiovascular disease (particularly atrial fibrillation-AF) among women with breast cancer is becoming a major issue. We aimed at determining the incidence of cardiovascular disease events (AF, arterial and cardiac events, venous-thromboembolism-VTE) in patients diagnosed with breast ca[r]
WOMEN’S HEALTH STATUS REPORT 2002 POTX
VT 2001: 54% of womenFacts:• In Vermont, 44 percent of women are over healthyweight (BMI 25+). Body Mass Index equals 704 timesweight (lbs.) divided by height (inches) squared (wt/ht2).• Nationally, overweight and obesity are more preva-lent among women in racial and ethnic minoritypopulations than[r]
20 Đọc thêm
CHAPTER 080 CANCER CELL BIOLOGY AND ANGIOGENESIS PART 9
solid tumors. HDAC inhibitors may target cancer cells via a number of mechanisms including upregulation of death receptors (DR4/5, FAS, and their ligands) and p21Cip1/Waf1, as well as inhibition of cell cycle checkpoints. Major therapeutic efforts are also under way to reverse the hype[r]
5 Đọc thêm
QUALITY OF LIFE AND BREAST CANCER: RELATIONSHIP TO PSYCHOSOCIAL VARIABLES POTX
change mode of control as well as the less studied accepting/letting go mode of control.On the other hand, it is crucial to emphasize the preliminary and tentative nature ofthese findings. Further, our small, homogeneous sample does restrict the generalizabilityof our study to other stages of bre[r]
19 Đọc thêm
CANCER OF THE TESTIS PPT
preservation of fertility) has led to the adoption of more conservative treatment regimens to minimize treatment-related morbidity. While in the past, patients with Stage I testis tumors routinely received additional treatment following orchiectomy, surgery followed by active sur-veillance al[r]
6 Đọc thêm